ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call
ProSomnus, Inc. announced it has postponed the release of its 2023 fourth quarter and full year financial results and the related investor conference call.
Uncategorized
Labcorp Presents New Research Demonstrating Clinical Impact of Precision Diagnostics in Guiding Biomarker-targeted Therapies for Patients with Epithelial Ovarian Cancer
Labcorp, a global leader of innovative and comprehensive laboratory services, presented the results from two studies at the 2024 SGO Annual Meeting on Women’s Cancer.
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
Fennec Pharmaceuticals Inc. and Norgine announced an exclusive licensing agreement under which Norgine will commercialize PEDMARQSI® in Europe, Australia and New Zealand.
Strong Fourth Quarter Powers 2023 Kelyniam Financials
Kelyniam Global, a maker of custom cranial implants, announced results for its year ended December 31, 2023.
Strong Fourth Quarter Powers 2023 Kelyniam Financials Read More »
Aadi Bioscience Presents New Subgroup Analysis of Patients with Advanced Malignant PEComa of Gynecologic Origin Treated with nab-Sirolimus at Society of Gynecologic Oncology (SGO)
Aadi Bioscience, Inc. announced patients in the AMPECT trial whose malignant perivascular epithelioid cell tumor had gynecologic origins experienced efficacy and safety consistent with the overall study population.
Everest Medicines Strengthens Management Team with Appointments of Chief Medical Officer and Chief Product Officer
Everest Medicines announced that the company has strengthened its management team with the appointments of Ms. Sandra Zeng as Chief Medical Officer and Mr. Rico Liang as Chief Product Officer.
FDA Action Alert: Orchard, ITF, Merck and More
The FDA will close out a hectic month of March with a flurry of target action dates, including ones for lymphoma and CKD anemia treatments.
Opinion: I Know I Want to Implement AI in My Company’s R&D. What Now?
Knowing that you want to integrate AI is one thing—but how do you actually do it? For biotech companies kickstarting their generative AI journey, here are four things to consider.
Opinion: I Know I Want to Implement AI in My Company’s R&D. What Now? Read More »
Recreando el sabor que tenían cervezas de hace miles de años
La primera cerveza de la que se tiene evidencia fue producida en China hace más de siete mil años, según lo que se deduce del estudio de jarras de cerámica que fueron halladas cerca del río Amarillo, y que eran utilizadas por las poblaciones de entonces para elabor …
Recreando el sabor que tenían cervezas de hace miles de años Read More »
La integridad de la barrera hematoencefálica en ciertas enfermedades neurodegenerativas
Algunos defectos en la red de vasos sanguíneos del sistema nervioso central se han asociado a síntomas iniciales de enfermedades neurodegenerativas como la enfermedad de Alzheimer y la esclerosis lateral amiotrófica (ELA). Esta red vascular tan compleja es la que aporta los nutr …
La integridad de la barrera hematoencefálica en ciertas enfermedades neurodegenerativas Read More »